Genetic head and neck malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183583
Who is this for?
Show terms as
21Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic head and neck malformation (Orphanet code 183583) is a broad classification category within Orphanet that encompasses a heterogeneous group of rare congenital malformations affecting the structures of the head and neck that have a confirmed or suspected genetic origin. This grouping includes a wide spectrum of developmental anomalies involving the craniofacial skeleton, ears, nose, oral cavity, pharynx, larynx, neck soft tissues, and associated structures. These malformations arise during embryonic development due to disruptions in the complex genetic programs that guide the formation of head and neck anatomy, often involving neural crest cell migration and differentiation, branchial arch development, or midline fusion processes. Because this is a classification group rather than a single discrete disease entity, the clinical presentation varies enormously depending on the specific condition involved. Affected individuals may present with craniofacial asymmetry, cleft lip or palate, ear malformations (microtia, anotia), mandibular or maxillary hypoplasia, nasal anomalies, branchial cleft cysts or fistulae, laryngeal or tracheal malformations, thyroid dysgenesis, or other structural abnormalities of the head and neck region. Many of these conditions are apparent at birth or during early childhood. Some occur as isolated findings, while others are part of broader syndromic conditions affecting multiple organ systems. Treatment approaches depend on the specific malformation and its severity. Management is typically multidisciplinary, involving clinical geneticists, craniofacial surgeons, otolaryngologists, orthodontists, speech therapists, and audiologists. Surgical correction is often the mainstay of treatment for structural anomalies, with timing and approach tailored to the individual condition. Genetic counseling is important for affected families to understand recurrence risks and inheritance patterns, which vary by specific diagnosis within this broad category.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

2 events
Jun 2025Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Ensem Therapeutics — PHASE1, PHASE2

TrialRECRUITING
Apr 2023First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Eli Lilly and Company — PHASE1, PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Genetic head and neck malformation.

View clinical trials →

No actively recruiting trials found for Genetic head and neck malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic head and neck malformation community →

Specialists

21 foundView all specialists →
PM
Peter H. O'Donnell, MD
ALTOONA, PA
Specialist
PI on 1 active trial
AM
AeRang Kim, MD
BETHESDA, MD
Specialist
PI on 2 active trials1 Genetic head and neck malformation publication
SM
Shivaani Kummar, MD
PORTLAND, OR
Specialist
PI on 5 active trials
KP
Kurt Fisher, MD, PhD
OMAHA, NE
Specialist
PI on 1 active trial
PP
Patricia L Dahia, MD, PhD
Specialist
PI on 2 active trials
DP
Dennis West, PhD
BLOOMFIELD, MI
Specialist
PI on 2 active trials
MP
Makoto Tahara, MD, PhD
Specialist
PI on 2 active trials
ZM
Zilong Yuan, MD
BOSTON, MA
Specialist
PI on 1 active trial
LL
Lisa Licitra
Specialist
PI on 2 active trials4 Genetic head and neck malformation publications
EM
Ezra Cohen, MD
Specialist
PI on 3 active trials
LM
Lisa McGregor
HERSHEY, PA
Specialist
PI on 2 active trials7 Genetic head and neck malformation publications
AP
Angèle SORIA, PU-PH
Specialist
PI on 1 active trial
GM
Galip Can Uyar, MD
Specialist
PI on 3 active trials1 Genetic head and neck malformation publication
CM
Chloé Bertolus, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic head and neck malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic head and neck malformationForum →

No community posts yet. Be the first to share your experience with Genetic head and neck malformation.

Start the conversation →

Latest news about Genetic head and neck malformation

Disease timeline:

New recruiting trial: First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A new clinical trial is recruiting patients for Genetic head and neck malformation

New recruiting trial: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

A new clinical trial is recruiting patients for Genetic head and neck malformation

New recruiting trial: A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

A new clinical trial is recruiting patients for Genetic head and neck malformation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic head and neck malformation

What is Genetic head and neck malformation?

Genetic head and neck malformation (Orphanet code 183583) is a broad classification category within Orphanet that encompasses a heterogeneous group of rare congenital malformations affecting the structures of the head and neck that have a confirmed or suspected genetic origin. This grouping includes a wide spectrum of developmental anomalies involving the craniofacial skeleton, ears, nose, oral cavity, pharynx, larynx, neck soft tissues, and associated structures. These malformations arise during embryonic development due to disruptions in the complex genetic programs that guide the formation

At what age does Genetic head and neck malformation typically begin?

Typical onset of Genetic head and neck malformation is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Genetic head and neck malformation?

21 specialists and care centers treating Genetic head and neck malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.